IBIS Megastudy- Pilot

StatusTerminated
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Why the trial stopped
On 5/1/25, the US NIH issued Notice: NOT-OD-25-104, which prohibited foreign subawards from being nested under a parent grant. Our pilot trial was scheduled for renewal on 8/1/25, and the NOA was delayed. Without funding, we had to halt the trial.

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 19, 2026
    • Primary endpoint revised
    • Sponsor's reason: On 5/1/25, the US NIH issued Notice: NOT-OD-25-104, which prohibited foreign subawards from being nested under a parent grant. Our pilot… to On 5/1/25, the US NIH issued Notice: NOT-OD-25-104, which prohibited foreign subawards from being nested under a parent grant. Our pilot…
    • Eligibility criteria expanded, about 6 words
  2. Trial status: Recruiting to Terminated Sponsor's reason: On 5/1/25, the US NIH issued Notice: NOT-OD-25-104, which prohibited foreign subawards from being nested under a parent grant. Our pilot…
    • Enrollment target: estimated 100 to confirmed 98
    • Primary and study completion dates changed from estimate of Dec 15, 2025 to Jul 31, 2025
    • Site details revised at 2 of 2 sites
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2025 to Mar 27, 2025
    • Site details revised at 2 of 2 sites
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
In this pilot study, the investigators will determine the feasibility and acceptability of multiple low-cost behavioral interventions, designed with end-user input, to promote HIV retesting among adults in rural Kenya and Uganda who have higher risk of HIV exposure.
Trial Details
NCT Number NCT06785103
Lead Sponsor University of California, San Francisco
Collaborators: University of Pennsylvania, Kenya Medical Research Institute, Infectious Diseases Research Collaboration, Uganda, University of California, Berkeley, Makerere University, National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 HIV
Enrollment 98 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov